Guidelines continue to strongly recommend co-testing in women ages 30 to 651-6
Evidence-based guidelines from many leading health organizations support the importance of co-testing:
|Ages 21-29||Ages 30-65||Ages > 65|
|ACOG4,5||Level A: ||Level A: ||Screening should be discontinued if patient has had adequate negative prior screening results and no history of CIN2+. Recommend continuing age-based screening for ≥20 years in those patients with a history of CIN2, CIN3, or adenocarcinoma in situ. Adequate negative prior screening results is defined as 3 consecutive negative Paps or 2 consecutive negative co-tests within the past 10 years, with the most recent test occurring within the past 5 years.|
|USPSTF2||Grade A: Pap alone every 3 years||Grade A: |
|Strong Recommendation: Pap alone every 3 years||Strong Recommendation: |
|Recommends: Pap alone every 3 years||Recommends: ||No comments|
NOTE: This table is a summary for convenience and should not be considered complete. For complete details, please see the respective guidelines.
ACOG = American College of Obstetricians and Gynecology; USPSTF = United States Preventive Services Task Force; ACS = American Cancer Society; ASCP = American Society for Clinical Pathology; ASCCP= American Society for Colposcopy and Cervical Pathology; HRSA = Health Resources & Services Administration; WPSI = Women’s Preventive Services InitiativeReferences
- American College of Obstetricians and Gynecologists. Practice advisory: cervical cancer screening (update). https://www.acog.org/Clinical-Guidance-and-Publications/Practice-Advisories/Practice-Advisory-Cervical-Cancer-Screening-Update?IsMobileSet=false. Published August 21, 2018. Accessed May 17, 2019.
- US Preventive Services Task Force. Final recommendation statement. Cervical cancer: screening. https://www. uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/cervical-cancer-screening2. Updated August 2018. Accessed May 17, 2019.
- Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012;62(3):147-172. doi: 10.3322/caac.21139
- American College of Obstetricians and Gynecologists. Practice bulletin no. 140: management of abnormal cervical cancer screening test results and cervical cancer precursors. 2013;122(6):1338-1367. doi: 10.1097/01.AOG.0000438960.31355.9e
- Committee on Practice Bulletins—Gynecology. Practice bulletin no. 168: cervical cancer screening and prevention. Obstet Gynecol. 2016;128(4):e111-e130. doi: 10.1097/AOG.0000000000001708
- Health Resources & Services Administration. Women’s preventive services guidelines. https://www.hrsa.gov/womens-guidelines/index.html. Last reviewed September 2018. Accessed June 10, 2019.